{ "api_version": "1", "request": { "url": "https://clinicaltrialsfind.com/api/v1/search.json?intervention=atorvastatin+%28Lipitor%29&page=2", "query": { "intervention": "atorvastatin (Lipitor)", "page": 2 }, "page_size": 10 }, "pagination": { "page": 2, "page_size": 10, "total_count": 308, "total_pages": 31, "next_page_url": "https://clinicaltrialsfind.com/api/v1/search.json?intervention=atorvastatin+%28Lipitor%29&page=3&page_size=10", "previous_page_url": "https://clinicaltrialsfind.com/api/v1/search.json?intervention=atorvastatin+%28Lipitor%29&page=1&page_size=10" }, "source": "remote", "last_synced_at": "2026-10-03T01:02:32.824Z", "attribution": "Data derived from public ClinicalTrials.gov records. The official record at https://clinicaltrials.gov/ remains the source of truth for current availability, contacts, and full study details.", "notes": [ "This endpoint exposes only public summary fields — no participant contact emails, phone numbers, or scraped investigator contact details.", "For contact information and full protocol detail, follow each trial's `official_url` to the ClinicalTrials.gov record.", "This API is a navigational aid. It does not provide medical advice, eligibility determinations, or compensation guarantees." ], "trials": [ { "nct_id": "NCT03830164", "title": "Pentoxifylline, Atorvastatin, and Vitamin E in Treating Patients With Erectile Dysfunction After Radiation Therapy for Prostate Cancer", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2" ], "conditions": [ "Male Erectile Disorder", "Prostate Adenocarcinoma", "Erectile Dysfunction, CTCAE", "Impotence" ], "interventions": [ { "name": "Atorvastatin", "type": "DRUG" }, { "name": "Pentoxifylline", "type": "DRUG" }, { "name": "Vitamin E Compound", "type": "DIETARY_SUPPLEMENT" } ], "intervention_types": [ "DRUG", "DIETARY_SUPPLEMENT" ], "sponsor": "M.D. Anderson Cancer Center", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "MALE", "summary": "18 Years and older · Male only" }, "enrollment_count": 14, "start_date": "2019-11-20", "completion_date": "2022-11-02", "has_results": true, "last_update_posted_date": "2023-10-17", "last_synced_at": "2026-10-03T01:02:32.824Z", "location_count": 1, "location_summary": "Houston, Texas", "locations": [ { "city": "Houston", "state": "Texas" } ], "official_url": "https://clinicaltrials.gov/study/NCT03830164" }, { "nct_id": "NCT02913664", "title": "Risk Reduction for Alzheimer's Disease", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2", "PHASE3" ], "conditions": [ "Cognitively Normal Older Adults", "Hypertension", "Subjective Cognitive Decline", "Family History of Alzheimer's Disease" ], "interventions": [ { "name": "Angiotensin II receptor blocker (ARB, losartan) and calcium channel blocker (CCB, amlodipine)", "type": "DRUG" }, { "name": "Aerobic Exercise Training", "type": "BEHAVIORAL" }, { "name": "Usual Care", "type": "OTHER" }, { "name": "Stretching Exercise", "type": "BEHAVIORAL" } ], "intervention_types": [ "DRUG", "BEHAVIORAL", "OTHER" ], "sponsor": "University of Texas Southwestern Medical Center", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "60 Years", "maximum_age": "85 Years", "sex": "ALL", "summary": "60 Years to 85 Years" }, "enrollment_count": 513, "start_date": "2017-02-02", "completion_date": "2022-01-31", "has_results": false, "last_update_posted_date": "2022-02-15", "last_synced_at": "2026-10-03T01:02:32.824Z", "location_count": 4, "location_summary": "Kansas City, Kansas • Baton Rouge, Louisiana • St Louis, Missouri + 1 more", "locations": [ { "city": "Kansas City", "state": "Kansas" }, { "city": "Baton Rouge", "state": "Louisiana" }, { "city": "St Louis", "state": "Missouri" }, { "city": "Dallas", "state": "Texas" } ], "official_url": "https://clinicaltrials.gov/study/NCT02913664" }, { "nct_id": "NCT00115830", "title": "Rho Kinase in Patients With Atherosclerosis", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE3" ], "conditions": [ "Atherosclerosis" ], "interventions": [ { "name": "Atorvastatin", "type": "DRUG" }, { "name": "Rosuvastatin", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Brigham and Women's Hospital", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "40 Years", "maximum_age": "80 Years", "sex": "ALL", "summary": "40 Years to 80 Years" }, "enrollment_count": 40, "start_date": "2004-12", "completion_date": "2007-02", "has_results": false, "last_update_posted_date": "2007-04-24", "last_synced_at": "2026-10-03T01:02:32.824Z", "location_count": 1, "location_summary": "Boston, Massachusetts", "locations": [ { "city": "Boston", "state": "Massachusetts" } ], "official_url": "https://clinicaltrials.gov/study/NCT00115830" }, { "nct_id": "NCT01163851", "title": "Pharmacokinetic And Pharmacodynamic Study Of A Single-Dose Of PF-04950615 (RN316) In Combination With Atorvastatin", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE1" ], "conditions": [ "Hypercholesterolemia", "Dyslipidemia" ], "interventions": [ { "name": "4 mg/kg", "type": "BIOLOGICAL" }, { "name": "0.5 mg/kg", "type": "BIOLOGICAL" } ], "intervention_types": [ "BIOLOGICAL" ], "sponsor": "Pfizer", "sponsor_class": "INDUSTRY", "healthy_volunteers": true, "eligibility": { "minimum_age": "18 Years", "maximum_age": "80 Years", "sex": "ALL", "summary": "18 Years to 80 Years" }, "enrollment_count": 25, "start_date": "2010-07", "completion_date": "2011-04", "has_results": true, "last_update_posted_date": "2018-03-01", "last_synced_at": "2026-10-03T01:02:32.824Z", "location_count": 5, "location_summary": "Peoria, Arizona • Phoenix, Arizona • Overland Park, Kansas", "locations": [ { "city": "Peoria", "state": "Arizona" }, { "city": "Phoenix", "state": "Arizona" }, { "city": "Phoenix", "state": "Arizona" }, { "city": "Overland Park", "state": "Kansas" }, { "city": "Overland Park", "state": "Kansas" } ], "official_url": "https://clinicaltrials.gov/study/NCT01163851" }, { "nct_id": "NCT01218204", "title": "A Study to Investigate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Administering Multiple Oral Doses of GSK1292263 Alone and With Atorvastatin", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2" ], "conditions": [ "Dyslipidaemias", "Dyslipidemias" ], "interventions": [ { "name": "10mg atorvastatin", "type": "DRUG" }, { "name": "80mg atorvastatin", "type": "DRUG" }, { "name": "GSK1292263 Placebo", "type": "DRUG" }, { "name": "100mg GSK1292263", "type": "DRUG" }, { "name": "300mg GSK1292263", "type": "DRUG" }, { "name": "800mg GSK1292263", "type": "DRUG" }, { "name": "10mg ezetimibe", "type": "DRUG" }, { "name": "Washout", "type": "OTHER" } ], "intervention_types": [ "DRUG", "OTHER" ], "sponsor": "GlaxoSmithKline", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": "75 Years", "sex": "ALL", "summary": "18 Years to 75 Years" }, "enrollment_count": 287, "start_date": "2010-09-14", "completion_date": "2011-06-29", "has_results": true, "last_update_posted_date": "2019-07-16", "last_synced_at": "2026-10-03T01:02:32.824Z", "location_count": 21, "location_summary": "Anniston, Alabama • Chula Vista, California • Stockton, California + 15 more", "locations": [ { "city": "Anniston", "state": "Alabama" }, { "city": "Chula Vista", "state": "California" }, { "city": "Stockton", "state": "California" }, { "city": "Jacksonville", "state": "Florida" }, { "city": "Miami", "state": "Florida" } ], "official_url": "https://clinicaltrials.gov/study/NCT01218204" }, { "nct_id": "NCT00143741", "title": "Use of Atorvastatin (Lipitor) to Decrease Panel Reactive Antibody Titers", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE1" ], "conditions": [ "End-Stage Kidney Disease" ], "interventions": [ { "name": "Atorvastatin (Lipitor)", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "University of Chicago", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": "75 Years", "sex": "ALL", "summary": "18 Years to 75 Years" }, "enrollment_count": 20, "start_date": "2005-05", "completion_date": "2011-07", "has_results": false, "last_update_posted_date": "2013-01-10", "last_synced_at": "2026-10-03T01:02:32.824Z", "location_count": 1, "location_summary": "Chicago, Illinois", "locations": [ { "city": "Chicago", "state": "Illinois" } ], "official_url": "https://clinicaltrials.gov/study/NCT00143741" }, { "nct_id": "NCT02029534", "title": "Intensive Statin Therapy Effect on Post-Operative Atrial Fibrillation (POAF)", "overall_status": "UNKNOWN", "study_type": "INTERVENTIONAL", "phases": [ "PHASE4" ], "conditions": [ "Cardiothoracic Surgery", "Post-operative Atrial Fibrillation" ], "interventions": [ { "name": "Atorvastatin 20 mg", "type": "DRUG" }, { "name": "Atorvastatin 80 mg", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Creighton University", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "19 Years", "maximum_age": null, "sex": "ALL", "summary": "19 Years and older" }, "enrollment_count": 200, "start_date": "2013-08", "completion_date": "2017-06", "has_results": false, "last_update_posted_date": "2016-06-16", "last_synced_at": "2026-10-03T01:02:32.824Z", "location_count": 1, "location_summary": "Omaha, Nebraska", "locations": [ { "city": "Omaha", "state": "Nebraska" } ], "official_url": "https://clinicaltrials.gov/study/NCT02029534" }, { "nct_id": "NCT01342211", "title": "A Multiple Dose Study of PF-04950615 (RN316) in Subjects on High Doses of Statins", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2" ], "conditions": [ "Hypercholesterolemia", "Dyslipidemia" ], "interventions": [ { "name": "Placebo", "type": "BIOLOGICAL" }, { "name": "Statin", "type": "DRUG" }, { "name": "PF-04950615 (RN316)", "type": "BIOLOGICAL" }, { "name": "Satin", "type": "DRUG" } ], "intervention_types": [ "BIOLOGICAL", "DRUG" ], "sponsor": "Pfizer", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 93, "start_date": "2011-07", "completion_date": "2012-06", "has_results": true, "last_update_posted_date": "2017-10-11", "last_synced_at": "2026-10-03T01:02:32.824Z", "location_count": 38, "location_summary": "Tustin, California • Walnut Creek, California • Clearwater, Florida + 25 more", "locations": [ { "city": "Tustin", "state": "California" }, { "city": "Walnut Creek", "state": "California" }, { "city": "Clearwater", "state": "Florida" }, { "city": "DeLand", "state": "Florida" }, { "city": "Doral", "state": "Florida" } ], "official_url": "https://clinicaltrials.gov/study/NCT01342211" }, { "nct_id": "NCT00134511", "title": "Study To Evaluate The Effect Of Torcetrapib/Atorvastatin In Patients With Genetic High Cholesterol Disorder", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE3" ], "conditions": [ "Hypercholesterolemia, Familial" ], "interventions": [ { "name": "Torcetrapib/atorvastatin", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Pfizer", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 30, "start_date": "2005-03", "completion_date": "2005-11", "has_results": false, "last_update_posted_date": "2007-11-07", "last_synced_at": "2026-10-03T01:02:32.824Z", "location_count": 1, "location_summary": "Boston, Massachusetts", "locations": [ { "city": "Boston", "state": "Massachusetts" } ], "official_url": "https://clinicaltrials.gov/study/NCT00134511" }, { "nct_id": "NCT02791958", "title": "Pharmacodynamic Equivalence of Ramipril 10 mg and Atorvastatin 40 mg Administered as a Cardiovascular (CV) Polypill Acetylsalicylic Acid-Atorvastatin-Ramipril (AAR) as Compared to Monotherapy", "overall_status": "UNKNOWN", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2" ], "conditions": [ "Hypertension" ], "interventions": [ { "name": "Cardiovascular Fixed Dose Combination Pill AAR", "type": "DRUG" }, { "name": "Atorvastatin 40 mg", "type": "DRUG" }, { "name": "Ramipril 10 mg", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Ferrer Internacional S.A.", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": "74 Years", "sex": "ALL", "summary": "18 Years to 74 Years" }, "enrollment_count": 528, "start_date": "2016-03", "completion_date": "2017-10", "has_results": false, "last_update_posted_date": "2017-04-10", "last_synced_at": "2026-10-03T01:02:32.824Z", "location_count": 36, "location_summary": "Birmingham, Alabama • Los Angeles, California • Sacramento, California + 29 more", "locations": [ { "city": "Birmingham", "state": "Alabama" }, { "city": "Los Angeles", "state": "California" }, { "city": "Sacramento", "state": "California" }, { "city": "Tustin", "state": "California" }, { "city": "West Hills", "state": "California" } ], "official_url": "https://clinicaltrials.gov/study/NCT02791958" } ] }